Furthermore, the biological pathways described such as brain inflammation, leaky blood-brain barriers, and insulin resistance are largely based on animal studies or general obesity research rather than direct testing in LC patients. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.